Quick Answer
Black Seed Stress Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: PCOS increases the risk of other disorders, including type 2 diabetes, dyslipidemia, high blood pressure, cancers, infertility, and metabolic diseases such as insulin resistance [,].
Key Takeaways
- 01PCOS increases the risk of other disorders, including type 2 diabetes, dyslipidemia, high blood pressure, cancers, infertility, and metabolic diseases such as insulin resistance [,]. [Dashti Sareh (2026)]
- 0214 15 17 Conventional pharmacological interventions, such as hormonal contraceptives, insulin sensitizers, and ovulation-inducing agents are effective in symptom control, but may be associated with side effects, contraindications, or limited patient adherence []. [Dashti Sareh (2026)]
- 03By consolidating recent findings, this review seeks to provide an evidence-based update to guide clinical practice and future research directions in integrating herbal therapies into PCOS management. [Dashti Sareh (2026)]
- 041 3 4 5 5 6 7 Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and the most common cause of infertility due to lack of ovulation [–]. [Dashti Sareh (2026)]
The current Migaku evidence database contains 2 reusable source documents for Black Seed Stress Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- PCOS increases the risk of other disorders, including type 2 diabetes, dyslipidemia, high blood pressure, cancers, infertility, and metabolic diseases such as insulin resistance [,]. [Dashti Sareh (2026); evidence level 1]
- 14 15 17 Conventional pharmacological interventions, such as hormonal contraceptives, insulin sensitizers, and ovulation-inducing agents are effective in symptom control, but may be associated with side effects, contraindications, or limited patient adherence []. [Dashti Sareh (2026); evidence level 1]
- By consolidating recent findings, this review seeks to provide an evidence-based update to guide clinical practice and future research directions in integrating herbal therapies into PCOS management. [Dashti Sareh (2026); evidence level 1]
- 1 3 4 5 5 6 7 Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and the most common cause of infertility due to lack of ovulation [–]. [Dashti Sareh (2026); evidence level 1]
- Severity, frequency and duration of migraine attacks, headache daily result (HDR), quality of life, migraine disability, mental health, anthropometric indices, blood pressure, and serum levels of calcitonin gene-related peptide (CGRP), vascular cell adhesion molecules-1, total antioxidant capacity, and malondialdehyde were measured at baseline and end of the trial. [Eshaghian N (2025); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review
- Effects of grape seed extract supplementation on inflammatory biomarkers, oxidative stress, clinical symptoms, and quality of life in patients with migraine: A double-blinded randomized placebo-controlled clinical trial.